Clinical Trial Update: Single and Multiple Ascending Dose Study of KN-002 [Phase 1]

View source ↗

Summary

This Clinical Trials update notes the completion of a Phase 1 single and multiple ascending dose study of KN-002 for asthma and chronic obstructive pulmonary di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• KN-002

Snippet

Sponsor: Kinaset Therapeutics Inc | Conditions: Asthma COPD | Phase 1 | Status: COMPLETED